225 related articles for article (PubMed ID: 9574822)
1. The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation.
Quartara L; Maggi CA
Neuropeptides; 1997 Dec; 31(6):537-63. PubMed ID: 9574822
[TBL] [Abstract][Full Text] [Related]
2. The tachykinin NK1 receptor in the brain: pharmacology and putative functions.
Saria A
Eur J Pharmacol; 1999 Jun; 375(1-3):51-60. PubMed ID: 10443564
[TBL] [Abstract][Full Text] [Related]
3. The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.
Kemel ML; Pérez S; Beaujouan JC; Jabourian M; Soubrié P; Glowinski J
J Neurochem; 2003 Oct; 87(2):487-96. PubMed ID: 14511126
[TBL] [Abstract][Full Text] [Related]
4. Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter.
Hall JM; Mitchell D; Morton IK
Br J Pharmacol; 1994 Jul; 112(3):985-91. PubMed ID: 7522864
[TBL] [Abstract][Full Text] [Related]
5. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
6. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
7. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist.
Cascieri MA; Ber E; Fong TM; Hale JJ; Tang F; Shiao LL; Mills SG; MacCoss M; Sadowski S; Tota MR; Strader CD
Eur J Pharmacol; 1997 May; 325(2-3):253-61. PubMed ID: 9163573
[TBL] [Abstract][Full Text] [Related]
9. Involvement of tachykinin NK1 receptors in plasma protein extravasation induced by tachykinins in the guinea pig upper airways.
Evangelista S; Paoli S; Giachetti A; Manzini S
Neuropeptides; 1997 Feb; 31(1):65-70. PubMed ID: 9574840
[TBL] [Abstract][Full Text] [Related]
10. Deciphering specificity and cross-reactivity in tachykinin NK1 and NK2 receptors.
Madsen JJ; Petersen JE; Christensen DP; Hansen JB; Schwartz TW; Frimurer TM; Olsen OH
J Biol Chem; 2023 Dec; 299(12):105438. PubMed ID: 37944618
[TBL] [Abstract][Full Text] [Related]
11. Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor.
Holst B; Zoffmann S; Elling CE; Hjorth SA; Schwartz TW
Mol Pharmacol; 1998 Jan; 53(1):166-75. PubMed ID: 9443945
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological studies of a library of NK1-Receptor Ligands Based on a 5-arylthiosubstituted 2-amino-4,6-diaryl-3-cyano-4H-pyran core: Switch from antagonist to agonist effect by chemical modification.
Recio R; Vengut-Climent E; Mouillac B; Orcel H; López-Lázaro M; Calderón-Montaño JM; Álvarez E; Khiar N; Fernández I
Eur J Med Chem; 2017 Sep; 138():644-660. PubMed ID: 28710964
[TBL] [Abstract][Full Text] [Related]
13. The unpredicted high affinities of a large number of naturally occurring tachykinins for chimeric NK1/NK3 receptors suggest a role for an inhibitory domain in determining receptor specificity.
Tian Y; Wu LH; Oxender DL; Chung FZ
J Biol Chem; 1996 Aug; 271(34):20250-7. PubMed ID: 8702757
[TBL] [Abstract][Full Text] [Related]
14. The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles.
Quartara L; Maggi CA
Neuropeptides; 1998 Feb; 32(1):1-49. PubMed ID: 9571643
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological characterisation of tachykinin receptors in the rat nucleus of the solitary tract and dorsal motor nucleus of the vagus in vitro.
Maubach KA; Jones RS
Br J Pharmacol; 1997 Nov; 122(6):1151-9. PubMed ID: 9401780
[TBL] [Abstract][Full Text] [Related]
16. Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands.
Turcatti G; Zoffmann S; Lowe JA; Drozda SE; Chassaing G; Schwartz TW; Chollet A
J Biol Chem; 1997 Aug; 272(34):21167-75. PubMed ID: 9261122
[TBL] [Abstract][Full Text] [Related]
17. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
[TBL] [Abstract][Full Text] [Related]
18. Effect of the non-peptide blocker (+/-) CP 96,345 on the cellular mechanism involved in the response to NK1 receptor stimulation in human skin fibroblasts.
Ziche M; Parenti A; Amerini S; Zawieja D; Maggi CA; Ledda F
Neuropeptides; 1996 Aug; 30(4):345-54. PubMed ID: 8914860
[TBL] [Abstract][Full Text] [Related]
19. Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor.
Nederpelt I; Bleeker D; Tuijt B; IJzerman AP; Heitman LH
Biochem Pharmacol; 2016 Oct; 118():88-95. PubMed ID: 27501920
[TBL] [Abstract][Full Text] [Related]
20. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
